Disclaimer - Important

These materials are not directed at or intended to be accessed by persons located outside India. these materials are being made available on this website to comply with securities and exchange board of india (issue of capital and disclosure requirements) regulations, 2018, as amended.

IMPORTANT : You must read and agree with the terms and conditions of the following disclaimer before continuing.

The following disclaimer applies to the Draft Red Herring Prospectus of Entero Healthcare Solutions Limited (the “Company”) dated September 13 - 2023 (the “Draft Red Herring Prospectus”) filed with the Securities and Exchange Board of India (“SEBI”), BSE Limited (“BSE”) and National Stock Exchange of India Limited (“NSE”, and together with BSE, the “Stock Exchanges”) and hosted on this website. In accessing the Draft Red Herring Prospectus, you agree to be bound by the following terms and conditions, including any modifications to them from time to time.

The Draft Red Herring Prospectus is directed at, and is intended for distribution to, and use by, residents of India only. The information in this portion of our website, including the Draft Red Herring Prospectus, is not for publication or distribution, directly or indirectly, in or into the United States. No part of the contents of the Draft Red Herring Prospectus shall be copied or duplicated in any form by any means, or redistributed.

The Draft Red Herring Prospectus has been hosted on this website as prescribed under Regulation 26(1) of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended (the “SEBI ICDR Regulations”). You are reminded that documents transmitted in electronic form may be altered or changed during the process of transmission and consequently, neither the Company nor any of its affiliates accepts any liability or responsibility whatsoever in respect of alterations or changes which have taken place during the course of transmission of electronic data.

The Draft Red Herring Prospectus does not constitute an offer to sell or an invitation to subscribe to the securities offered in any jurisdiction to any person to whom it is unlawful to make an offer or invitation in such jurisdiction and is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where (a) distribution or use of such information would be contrary to law or regulation; or (b) the Company or any of its affiliates would by virtue of such distribution become subject to new or additional registration, licensing or other regulatory requirements. The Equity Shares offered in the Offer have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws in the United States, and unless so registered may not be offered or sold within the United States, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the U.S. Securities Act and applicable state securities laws. Accordingly, the Equity Shares are being offered and sold (a) within the United States solely to persons reasonably believed to be “qualified institutional buyers” (as defined in Rule 144A under the U.S. Securities Act) in transactions exempt from, or not subject to, the registration requirements of the U.S. Securities Act, and (b) outside the United States in offshore transactions in compliance with Regulation S under the U.S. Securities Act and the applicable laws of the jurisdiction where those offers and sales are made.

Any person into whose possession the Draft Red Herring Prospectus comes is required to inform himself or herself about and to observe any such restrictions. Neither the Company nor any of its affiliates is soliciting any action based on the Draft Red Herring Prospectus, and it should not be construed as an offer to sell or the solicitation of an offer to buy any securities. Potential investors should not rely on the Draft Red Herring Prospectus for any investment decision. Any potential investor should note that investment in the securities involves a high degree of risk. For details, potential investors should refer to the red herring prospectus, including the section titled “Risk Factors”, when available.

Neither the Company nor any of its affiliates will be responsible for any loss or damage that could result from interception and interpretation by any third parties of any information being made available to you through this website. The Company and its affiliates cannot and do not guarantee the accuracy, timeliness or completeness of the information being made available to you in the Draft Red Herring Prospectus beyond the date of the Draft Red Herring Prospectus. The Company and its affiliates will not be responsible for any loss to any person or entity caused by any shortcoming, defect or inaccuracy which may have inadvertently or otherwise crept into the website. Neither the Company, any of its affiliates nor their directors, officers and employees will be liable or have any responsibility of any kind for any loss or damage that you incur in the event of any failure or disruption of this website, or resulting from the act or omission of any other party involved in making this website or the data contained therein available to you, or from any other cause relating to your access to, inability to access, or use of the website or these materials.

If you are not permitted to view the materials on this website or are in any doubt as to whether you are permitted to view these materials, please exit this webpage.

To access this information, you must confirm by pressing on the button marked "I Confirm" that, at the time of access you are located in India. If you cannot make this confirmation, you must press the button marked "I Do Not Confirm".

The documentation contained in these pages is posted solely to comply with Indian legal and regulatory requirements. Making the information contained herein available in electronic format does not constitute an offer to sell, the solicitation of an offer to buy, or a recommendation to buy or sell securities of the Company in the United States or in any other jurisdiction, including without limitation, India.



Disclaimer - Important

THESE MATERIALS ARE NOT DIRECTED AT OR INTENDED TO BE ACCESSED BY PERSONS LOCATED OUTSIDE INDIA.

IMPORTANT : You must read and agree with the terms and conditions of the following disclaimer before continuing.

The following disclaimer applies to the Red Herring Prospectus of Entero Healthcare Solutions Limited (the “Company”) dated February 5, 2024 (the “Red Herring Prospectus”) filed with the Registrar of Companies, Delhi and Haryana at New Delhi and thereafter with the Securities and Exchange Board of India (“SEBI”) and the BSE Limited and the National Stock Exchange of India Limited, in relation to the initial public offering of the equity shares of face value of ₹ 10 each (“Equity Shares”) of the Company (“Offer”).

THE RED HERRING PROSPECTUS IS BEING MADE AVAILABLE ON THIS WEBSITE TO COMPLY WITH SECURITIES AND EXCHANGE BOARD OF INDIA (ISSUE OF CAPITAL AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2018, AS AMENDED (“SEBI ICDR REGULATIONS”). You are advised to read this disclaimer carefully before reading, accessing or making any other use of the Red Herring Prospectus. In accessing the Red Herring Prospectus, you agree to be bound by the following terms and conditions, including any modifications to them from time to time.

The Red Herring Prospectus is directed at, and is intended for distribution to, and use by, residents of India only. The information in this portion of our website, including the Red Herring Prospectus, is not for publication or distribution, directly or indirectly, in or into the United States. No part of the contents of the Red Herring Prospectus shall be copied or duplicated in any form by any means, or redistributed. The information contained in the Red Herring Prospectus may not be updated since its original publication date and may not reflect the latest updates.

The Red Herring Prospectus has been hosted on this website as prescribed under Regulation 26 of the SEBI ICDR Regulations. You are reminded that documents transmitted in electronic form may be altered or changed during the process of transmission and consequently, neither the Company nor any of its affiliates accepts any liability or responsibility whatsoever in respect of alterations or changes which have taken place during the course of transmission of electronic data.

The Red Herring Prospectus does not constitute an offer to sell or an invitation to subscribe to the securities offered in any jurisdiction to any person to whom it is unlawful to make an offer or invitation in such jurisdiction and is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where (a) distribution or use of such information would be contrary to law or regulation; or (b) the Company or any of its affiliates would by virtue of such distribution become subject to new or additional registration, licensing or other regulatory requirements. The Equity Shares offered in the Offer have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws in the United States, and unless so registered may not be offered or sold within the United States, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the U.S. Securities Act and applicable state securities laws. Accordingly, such Equity Shares are being offered and sold (i) outside of the United States in “offshore transactions” as defined in and in compliance with Regulation S under the U.S. Securities Act and the applicable laws of the jurisdiction where those offers and sales occur; and (ii) to “qualified institutional buyers” (as defined in Rule 144A under the U.S. Securities Act) pursuant to Section 4(a) of the U.S. Securities Act. No person outside India is eligible to bid for Equity Shares in the Offer unless that person has received the preliminary offering memorandum for the Offer, which comprises the Red Herring Prospectus and the preliminary international wrap (which contains, among other things, the selling restrictions for the Offer outside India).

Any person into whose possession the Red Herring Prospectus comes is required to inform himself or herself about and to observe any such restrictions.

Neither the Company nor any of its affiliates will be responsible for any loss or damage that could result from interception and interpretation by any third parties of any information being made available to you through this website. The Company and its affiliates cannot and do not guarantee the accuracy, timeliness or completeness of the information being made available to you in the Red Herring Prospectus beyond the date of the Red Herring Prospectus. The information in the Red Herring Prospectus is as of the date thereof and neither the Company nor its affiliates, directors or employees are under any obligation to update or revise the Red Herring Prospectus to reflect circumstances arising after the date thereof.

Any potential investor should note that investment in equity shares involves a high degree of risk and for details relating to such risks, see the section titled “Risk Factors” in the Red Herring Prospectus. Any decision on whether to invest in the equity shares described in the red herring prospectus of the Company dated February 5, 2024 (“RHP”), must be made solely on the basis of the RHP. As there may be material changes in the draft red herring prospectus dated September 13, 2023 (the “DRHP”) versus the RHP, potential investors should not have relied on the DRHP.

The Company and its affiliates will not be responsible for any loss to any person or entity caused by any shortcoming, defect or inaccuracy which may have inadvertently or otherwise crept into the website. Neither the Company, any of its affiliates nor their directors, officers and employees will be liable or have any responsibility of any kind for any loss or damage that you incur in the event of any failure or disruption of this website, or resulting from the act or omission of any other party involved in making this website or the data contained therein available to you, or from any other cause relating to your access to, inability to access, or use of the website or these materials.

If you are not permitted to view the materials on this website or are in any doubt as to whether you are permitted to view these materials, please exit this webpage.

To access this information, you must confirm by pressing on the button marked "I Confirm" that, at the time of access you are located in India. If you cannot make this confirmation, you must press the button marked "I Do Not Confirm". The documentation contained in these pages is posted solely to comply with Indian legal and regulatory requirements. Making the information contained herein available in electronic format does not constitute an offer to sell, the solicitation of an offer to buy, or a recommendation to buy or sell securities of the Company in the United States or in any other jurisdiction, including without limitation, India.



Disclaimer - Important

THESE MATERIALS ARE NOT DIRECTED AT OR INTENDED TO BE ACCESSED BY PERSONS LOCATED OUTSIDE INDIA.

IMPORTANT : You must read and agree with the terms and conditions of the following disclaimer before continuing.

The following disclaimer applies to the Prospectus of Entero Healthcare Solutions Limited (the “Company”) dated February 13, 2024 (the “Prospectus”) filed with the Registrar of Companies, Delhi and Haryana at New Delhi and thereafter with the Securities and Exchange Board of India (“SEBI”) and the BSE Limited and the National Stock Exchange of India Limited, in relation to the initial public offering of the equity shares of face value of ₹ 10 each (“Equity Shares”) of the Company (“Offer”).

THE PROSPECTUS IS BEING MADE AVAILABLE ON THIS WEBSITE TO COMPLY WITH SECURITIES AND EXCHANGE BOARD OF INDIA (ISSUE OF CAPITAL AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2018, AS AMENDED (“SEBI ICDR REGULATIONS”). You are advised to read this disclaimer carefully before reading, accessing or making any other use of the Prospectus. In accessing the Prospectus, you agree to be bound by the following terms and conditions, including any modifications to them from time to time.

The Prospectus is directed at, and is intended for distribution to, and use by, residents of India only. The information in this portion of our website, including the Prospectus, is not for publication or distribution, directly or indirectly, in or into the United States. No part of the contents of the Prospectus shall be copied or duplicated in any form by any means, or redistributed.

The Prospectus has been hosted on this website as prescribed under Regulation 26 of the SEBI ICDR Regulations. You are reminded that documents transmitted in electronic form may be altered or changed during the process of transmission and consequently, neither the Company nor any of its affiliates accepts any liability or responsibility whatsoever in respect of alterations or changes which have taken place during the course of transmission of electronic data.

The Prospectus does not constitute an offer to sell or an invitation to subscribe to the securities offered in any jurisdiction to any person to whom it is unlawful to make an offer or invitation in such jurisdiction and is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where (a) distribution or use of such information would be contrary to law or regulation; or (b) the Company or any of its affiliates would by virtue of such distribution become subject to new or additional registration, licensing or other regulatory requirements. The Equity Shares offered in the Offer have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws in the United States, and unless so registered may not be offered or sold within the United States, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the U.S. Securities Act and applicable state securities laws. Accordingly, such Equity Shares are being offered and sold (i) outside of the United States in “offshore transactions” as defined in and in compliance with Regulation S under the U.S. Securities Act and the applicable laws of the jurisdiction where those offers and sales occur; and (ii) to “qualified institutional buyers” (as defined in Rule 144A under the U.S. Securities Act) pursuant to Section 4(a) of the U.S. Securities Act. No person outside India is eligible to bid for Equity Shares in the Offer unless that person has received the preliminary offering memorandum for the Offer, which comprises the red herring prospectus dated February 5, 2024 and the preliminary international wrap (which contains, among other things, the selling restrictions for the Offer outside India).

Any person into whose possession the Prospectus comes is required to inform himself or herself about and to observe any such restrictions.

Neither the Company nor any of its affiliates will be responsible for any loss or damage that could result from interception and interpretation by any third parties of any information being made available to you through this website. The Company and its affiliates cannot and do not guarantee the accuracy, timeliness or completeness of the information being made available to you in the Prospectus beyond the date of the Prospectus. The information in the Prospectus is as of the date thereof and neither the Company nor its affiliates, directors or employees are under any obligation to update or revise the Prospectus to reflect circumstances arising after the date thereof.

Any potential investor should note that investment in equity shares involves a high degree of risk and for details relating to such risks, see the section titled “Risk Factors” of the Prospectus.

The Company and its affiliates will not be responsible for any loss to any person or entity caused by any shortcoming, defect or inaccuracy which may have inadvertently or otherwise crept into the website. Neither the Company, any of its affiliates nor their directors, officers and employees will be liable or have any responsibility of any kind for any loss or damage that you incur in the event of any failure or disruption of this website, or resulting from the act or omission of any other party involved in making this website or the data contained therein available to you, or from any other cause relating to your access to, inability to access, or use of the website or these materials.

If you are not permitted to view the materials on this website or are in any doubt as to whether you are permitted to view these materials, please exit this webpage.

To access this information, you must confirm by pressing on the button marked "I Confirm" that, at the time of access you are located in India. If you cannot make this confirmation, you must press the button marked "I Do Not Confirm".

The documentation contained in these pages is posted solely to comply with Indian legal and regulatory requirements. Making the information contained herein available in electronic format does not constitute an offer to sell, the solicitation of an offer to buy, or a recommendation to buy or sell securities of the Company in the United States or in any other jurisdiction, including without limitation, India.



ENTERO DIRECT DISTRIBUTOR- RETAILER Connect
ENTERO DIRECT MANUFACTURING - DISTRIBUTOR CONNECT
CRM - ENTERO CUSTOMER CONNECT
ERP (ENTERPRISE RESOURCE PLANNING)
B.I (BUSINESS INTELLIGENCE)
MDM (MASTER DATA MANAGEMENT)
WAREHOUSE APPLICATION

Technology Solutions

ENTERO IT Solutions, is a digital platform that serves the needs of all the participants involved in the Pharma supply chain land scape of India. Entero Healthcare Solution has come up with a one-stop solution to manage your orders, sales, payments, deliveries, return management, track inventories, loyalty points, and more that can be conveniently run across the nation through Entero. The Entero Direct V1 platform is available to create a seamless flow between the Distributor and Retailer while the Entero Direct V2 platform is available to bridge the gap between Manufacturer and Distributors. Our application is available on both Android and iOS to bridge the gap between the retailers and distributors to run their businesses in full swing. Smart tools like CRM, BI, MDM, and ERP are introduced on the application to make the lives of the distributors, manufacturers, and retailers hassle-free. You can stay ahead of the pack by simply managing your orders on ENTERO DIRECT without burning a hole in your pocket for the tasks worth a fortune. [Read More]

ENTERO DIRECT DISTRIBUTOR- RETAILER CONNECT

Entero Direct Distributor to Retailer connect is a web based application specifically made to cater the needs of both the retailer and distributors. Both are required to login through their login credentials and ED will act as a bridge between retailer and distributor. The retailer can order online from any distributor from the list of available distributors and the distributor will get notify by the order. Once approved, we will start delivering the products to the retailer. Entero Direct creates very smooth and hassle-free channel, where distributor and retailer can feel the ease of doing business without wasting time and money. [Read More]

ENTERO DIRECT creates a free flowing channel by bringing Retailer and distributor on a digital platform where all the hurdles are managed by ENTERO DIRECT smart Web and phone based application. Below are some of its features.

Order Management
Application helps to view real time stock position, place order anytime with improved accuracy. [Read More]
Dashboard
One of the unique features of Entero direct is that it acts as a nerve center of operations in our organization. It provides live business insight through dynamic graphs, diagrams and tables for better understanding. [Read More]
Field Force Management
A distributor can keep close watch on its field force with the help of our phone application. User can assign chemists, routes and area to a sales man. [Read More]
Payment Collection
ENTERO direct enables a distributor to collect payment in most systematic manner. ENTERO direct enables a distributor to collect payment in most systematic manner. [Read More]
Delivery Management
With Entero direct makes it a lot easier to dispatch orders to retailers. It plans the route to be followed by delivery team and collect acknowledgments through phone application. [Read More]
Return Management
ENTERO Direct cuts short the lengthy process of return management. ENTERO Direct cuts short the lengthy process of return management. [Read More]

ENTERO DIRECT SALESMAN APPLICATION

Entero Direct mobile based application is specifically made for the salesman. A person can be logged in by their IMEI number. The salesman can get the order directly from the retailers themselves or from the distributor. The salesman will be shown the list of customers which he is expected to visit on the daily basis. This application will make the process hassle- free where the salesman will pick the products from the distributor and deliver it to its customers. On delivering, he can also collect payment by various payment methods available. Placing orders is now even easier and has become hassle-free with Entero - order online/offline and on the go with simplified order management services with live access to real-time data round the clock [Read More]
Live Inventory

The application helps to keep track of the live inventory to serve smooth order placement.

In-stock product

This feature will help you access the products that are in stock without having
you to crunch on the big numbers.

Real-Time order status

Allows you to observe the trail of the order placed.

Outstanding Details

Enables you to keep a track of the outstanding balances along with the order details without having to maintain records manually.

Dynamic Dashboard:

The dashboard allows quick access to active features to draft your orders, learn about the ongoing schemes, orders, and more.

24x7 Order Placement

Allows you to place an order from anywhere and anytime without any time limitations.

Loyalty Program

Earn rewards by simply using the ENTERO DIRECT application with the loyalty program.

All Stockist

Get information about the stockist for the required product to save time.

ENTERO DIRECT MANUFACTURING - DISTRIBUTOR CONNECT

ENTERO DIRECT is a cloud based SaaS solution aimed to resolve current pharma supply chain challenges. Under current pharma supply chain setup, there are many hurdles that make the reach of medicine difficult from a manufacturer to patient. These hurdles in Manufacturer to chemist connect are lack of integration, manual process, low tech adoption and limited reach.

Entero Direct creates a free flowing channel by bringing Manufacturer and Distributor on a digital platform where all the hurdles are managed by Entero Direct smart Web. Some of its features are :

Purchase Order Management

Entero Direct helps a distributor to manage purchase order, share approved & billed quantity and share invoice. Purchase orders are system generated and editing can be done according to the need.

Dashboard

One of the unique features of Entero Direct it acts as a nerve center of operations. It depicts different information in graphs, diagrams and tables for better understanding.

Medical Representative Performance

A manufacturer can even keep close watch on its medical representatives with the help of Entero Direct phone application.

Secondary Insights

Entero Direct enables the manufacturer to gain the in depth knowledge of all information happening in its firm. Entero Direct provides snapshot and detailed reports.

Information Exchange

Entero Direct lets user to create and generate different kinds of reports that enable timely sharing of trade related information in an effective and efficient manner.

CRM - ENTERO CUSTOMER CONNECT

Customer relationship management (CRM) is our in-house tool of managing interactions with existing as well as past and potential customers. It is one of the many different approaches that allows us to manage and analyze its own interactions with the past, current and potential customers. Customer relationship management (CRM) is our in-house tool of managing interactions with existing as well as past and potential customers. It is one of the many different approaches that allows us to manage and analyze its own interactions with the past, current and potential customers. [Read More]

Here are some of the benefits our CRM:

Identify and categorize
leads
Increase referrals from
existing customers
Continuously Improve
products and services
Cost-effectiveness and
scalability

ERP (ENTERPRISE RESOURCE PLANNING)

Entero ERP is a real-time access to data and an easy to use interface in ERP solutions form an integral part of our business strategy by providing a collaborative environment. Entero ERP system integrates and automates the main functionality of our organization thereby facilitating the flow of information among the different functions of an enterprise, while also permitting information sharing across organizational unit. Information is available to all stakeholders, from employees to customers and suppliers, enabling smoother transactions, a higher velocity in decisions and faster turnarounds. [Read More]

Some of the features of our ERP are:

Regulatory compliance
Our own ENTERO ERP system can manage comprehensive compliance amid continuous changes in the regulatory landscape. ­­­Compliance managers can set triggers, validate internal protocols, and initiate checks and balances using an ERP. Similarly, it helps in document management that forms the core of statutory vigilance and audits. Recording all historical data of every process and related documentation is mandatory for audit checks and future analysis.  [Read More]
Inventory and material management
ENTERO ERP offers modules that allow inventory managers to control pilferage and monitor inventory levels. All material requirements for production are maintained in real time. [Read More]
Sales and marketing management
An ERP system can help with sales order processing and contract management instantly by using pre-defined templates. It can also store and manage customer records and history; create competitive price quote basis past data, map this information with respect to a sales order, and create automated marketing workflows. [Read More]
On-Demand Reports
Get access to all the reports from inward registers, price variance, stock ledgers to sales order reports at your fingertips. [Read More]

B.I (BUSINESS INTELLIGENCE)

The ENTERO business analysis tool is a sales dashboard with a visual representation of our sales data. It will pull the real time sale data and the sales information can often be filtered by different time periods, HQs, Divisions and other key parameters. Tool provides an overview of your key performance indicators (KPIs) and shows us how our sales team is performing towards our goals and revenue targets. Sales leaders use these metrics to track progress toward goals, planning and make decisions and identify issues before they become large problems. [Read More]

MDM (MASTER DATA MANAGEMENT)

Entero Master data management (MDM) is a comprehensive method to define and manage our critical data. It provides a single, trusted view of data across our enterprise, agile self-service access, analytical graph-based exploration, governance and a user-friendly dashboard. Master data management solutions from Entero establish a single, trusted, 360-degree view of data and enable users to deliver better business insights through self-service analytics. MDM offers more than just a cleaner path to regulatory compliance. As better, more accessible data helps streamline processes and speed strategic decisions backed by analytics and data-driven insights, the resulting clarity and consistency can also drive internal benefits. It also helps us better prepared to satisfy information needs. [Read More]

WAREHOUSE APPLICATION

This mobile based application is build to monitor the day to day activities of our in-house warehouses. At every stage we have the system of checks and balances. Our sole agenda is to make the process effortless and less time bound.
Assignee

Whenever the request is made, the assigner will login through his credentials and assign the bucket to the product for which the request is made and it will be notified to the picker.

CHECKER

After the picker picks the consignment, the pick list will be sent to the checker who will cross verify the products received. And will give the confirmation to proceed with the Invoice

PICKER

The picker on visiting the warehouse will check for the bucket number assigned and log in with credentials and then will start picking the products. On finding the products as inappropriate or quantity/price mismatch, he can mention it in the application and ticket will be generated to check and verify.

Get The App Now !

Download the mobile app to manage your business on the go!